ARCHIVED WEBPAGE: This web page is available for historical purposes. CDC is no longer updating this web page and it may not reflect CDC's current COVID-19 guidance. For the latest information, visit CDC's COVID-19 home page.
Massachusetts Community Mitigation
CDC’s recommendations for implementation of mitigation strategies for Massachusetts, based on current situation with COVID-19 transmission
Note: Massachusetts has recently implemented many interventions included in the CDC guidance (https://www.cdc.gov/coronavirus/2019-ncov/community/index.html).
The most recent recommendations from Massachusetts can be found at: https://www.mass.gov/resource/information-on-the-outbreak-of-coronavirus-disease-2019-covid-19external icon
The following describes CDC recommendations for community interventions in Massachusetts.
Bottom Line Up Front:
At this time, most of the cases of COVID-19 are related to a single cluster associated with a conference at a hotel in Boston, MA. Due to the current level of COVID-19 transmission in Massachusetts, CDC recommends certain community mitigation activities to help slow the spread of COVID-19 into the community and to protect vulnerable members of the community. CDC recommends the following interventions be implemented at this time (Table). These recommendations may be updated, if necessary, based on any changes in the current local situation.
The goals for using mitigation strategies for Massachusetts are to reduce the spread of COVID-19 in the community and to protect:
- Individuals at increased risk for severe illness, including older adults and persons of any age with underlying health conditions (See Appendix A).
- The healthcare workforce and critical infrastructure workforces
These approaches are used to minimize morbidity and mortality caused by COVID-19 and minimize social and economic impacts of COVID-19. Individuals, communities, businesses, and healthcare organizations are all part of a community mitigation strategy.
- Emphasizing individual responsibility for implementation of recommended personal-level actions,
- Empowering businesses, schools, and community organizations to implement recommended actions, particularly in ways that protect persons at risk of severe illness such as older adults and persons with serious underlying health conditions (e.g., people requiring dialysis , or those with congestive heart failure or emphysema)
- Focusing on settings that provide critical services to implement recommended actions to protect critical infrastructure and individuals at risk of severe disease
- Minimizing disruptions to daily life to the extent possible
Table. Community mitigation strategies for Massachusetts
|For Every Individual and Families at Home||
|For Every School/Childcare Facility||
|For Every Assisted Living Facility, Senior Living Facility, and Adult Day Programs||
|Every Community and Faith-Based Organization||
|Healthcare Settings and Healthcare Providers (Including Outpatient, Nursing Homes/Long-Term Care Facilities, Inpatient, Telehealth)||
Appendix A: Underlying medical conditions that may increase the risk of serious COVID-19 for individuals of any age.
- Blood disorders (e.g., sickle cell disease or on blood thinners)
- Chronic kidney disease as defined by your doctor. Patient has been told to avoid or reduce the dose of medications because kidney disease, or is under treatment for kidney disease, including receiving dialysis
- Chronic liver disease as defined by your doctor. (e.g., cirrhosis, chronic hepatitis) Patient has been told to avoid or reduce the dose of medications because liver disease or is under treatment for liver disease.
- Compromised immune system (immunosuppression) (e.g., seeing a doctor for cancer and treatment such as chemotherapy or radiation, received an organ or bone marrow transplant, taking high doses of corticosteroids or other immunosuppressant medications, HIV or AIDS)
- Current or recent pregnancy in the last two weeks
- Endocrine disorders (e.g., diabetes mellitus)
- Metabolic disorders (such as inherited metabolic disorders and mitochondrial disorders)
- Heart disease (such as congenital heart disease, congestive heart failure and coronary artery disease)
- Lung disease including asthma or chronic obstructive pulmonary disease (chronic bronchitis or emphysema) or other chronic conditions associated with impaired lung function or that require home oxygen
- Neurological and neurologic and neurodevelopment conditions [including disorders of the brain, spinal cord, peripheral nerve, and muscle such as cerebral palsy, epilepsy (seizure disorders), stroke, intellectual disability, moderate to severe developmental delay, muscular dystrophy, or spinal cord injury].